Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery

Lignende værker

• A novel drug discovery strategy: Mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways
  af: Zhuang, Chunlin, et al.
  Udgivet: (2014)
• Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
  af: Yahui Huang, et al.
  Udgivet: (2020-07-01)
• Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
  af: Huang, Yahui, et al.
  Udgivet: (2020)
• Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors
  af: Fang, Kun, et al.
  Udgivet: (2018)
• Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide
  af: Wu, Ying, et al.
  Udgivet: (2019)